ID   HT-29-D9
AC   CVCL_4Z22
SY   HT 29-D9; HT29-D9
DR   cancercelllines; CVCL_4Z22
DR   Wikidata; Q54896513
RX   PubMed=3543033;
CC   Population: Caucasian.
CC   Doubling time: 36 hours (PubMed=3543033).
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 17
//
RX   PubMed=3543033; DOI=10.1242/jcs.83.1.235;
RA   Fantini J., Abadie B., Tirard A., Remy L., Ripert J.-P., El-Battari A.,
RA   Marvaldi J.;
RT   "Spontaneous and induced dome formation by two clonal cell populations
RT   derived from a human adenocarcinoma cell line, HT29.";
RL   J. Cell Sci. 83:235-249(1986).
//